EUROCORD was initially the name given to the International Registry of Umbilical Cord Transplants and Stem Cell Therapies founded by Professor Eliane Gluckman in 1995. The registry rapidly gave rise to many scientific projects, collaborations and publications in both malignant and non-malignant hematological diseases. In 2007, Professor Gluckman decided to bring them all together under the umbrella of a new, non-profit association. Today, the name EUROCORD refers to the Association and all the projects and activities that continue to emerge from its growing registry. In July 2010, the registry was transferred to the Agence de la Biomédecine, a national agency for public administration affiliated with the French Ministry of Health, competent in organ, tissue and cell donations and transplantations.
The EUROCORD study group located at the Saint-Louis Hospital in Paris is in charge of the collection, analyses and interpretation of the clinical data and outcomes of patients transplanted with umbilical cord blood. In association with the European Society for Blood and Marrow Transplantation (EBMT) and the Société Française de Greffe de Moelle (SFGM), EUROCORD continues to collect and validate clinical data from patients transplanted with umbilical cord blood for haematological diseases.
MONACORD is a project of EUROCORD born in 2012 thanks to the support of HSH Prince Albert II and the Government of the Principality of Monaco. MONACORD is hosted at the Centre Scientifique de Monaco (CSM), as a part of its Department of Medical Biology. The goals of MONACORD include the development of clinical recommendations for the management of sickle cell disease (SCD) and other hemoglobinopathies, and the launch and coordination of projects designed to improve the diagnosis and treatment of SCD, including hematopoietic stem cell transplantation and other innovative cell therapies. MONACORD also aims to disseminate knowledge on these topics, in particular to economically developing countries in Africa and elsewhere.
